Trial Profile
A Dose Finding Trial for Angiotensin II in Hypertensive Adults on Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers With Anesthesia-Mediated Hypotension
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 09 May 2023
Price :
$35
*
At a glance
- Drugs Angiotensin II (Primary)
- Indications Hypotension
- Focus Therapeutic Use
- 02 May 2023 Planned End Date changed from 1 Dec 2023 to 1 Dec 2024.
- 02 May 2023 Planned primary completion date changed from 1 Dec 2023 to 1 Dec 2024.
- 31 May 2022 Planned End Date changed from 1 Oct 2022 to 1 Dec 2023.